Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sepracor Announces Submission of STEDESA() New Drug Application to FDA for Adjunctive Treatment of Epilepsy
Sepracor Announces Submission of STEDESA() New Drug Application to FDA for Adjunctive Treatment of Epilepsy
Sepracor Announces Submission of STEDESA() New Drug Application to FDA for Adjunctive Treatment of Epilepsy
Submitted by
admin
on March 31, 2009 - 7:07am
Source:
Yahoo
News Tags:
Sepracor
NDA
FDA
epilepsy
Stedesa
Headline:
Sepracor Announces Submission of STEDESA() New Drug Application to FDA for Adjunctive Treatment of Epilepsy
Do Not Allow Advertisers to Use My Personal information
